Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dattatraya Patil

Showing results (101-110 of 144) with videos related to

Pageof 15
Sort By:
BJU International|August 11, 2020
Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC)Brittney H Cotta, Margaret F Meagher, Dattatraya Patil, et al.
Clinical Genitourinary Cancer|January 1, 2023
Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFRJulia H Yuan, Hajime Tanaka, Dattatraya Patil, et al.
Clinical Genitourinary Cancer|April 26, 2026
Utilization, Cost, and Subsequent Salvage Treatment of Ablative Therapies for Localized Prostate Cancer in the United StatesNikhil T Sebastian, Dattatraya Patil, Pretesh R Patel, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Impact of Elevated C-Reactive Protein on Survival Outcomes of Patients with Small Renal Masses: A Retrospective Multicenter AnalysisMargaret F Meagher, Natalie Birouty, Giacomo Musso, et al.
The Oncologist|January 6, 2026
An Increase in Splenic Volume After First-Line Immunotherapy is Associated with Worse PFS in Patients with Metastatic Renal Cell CarcinomaGregory Palmateer, Ahmet Yildirim, Taylor Goodstein, et al.
European Journal of Radiology|April 25, 2018
Prospective evaluation of fluciclovine (<sup>18</sup>F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patientsOladunni Akin-Akintayo, Funmilayo Tade, Pardeep Mittal, et al.
Urology|September 10, 2023
Contemporary Patients Have Better Perioperative Outcomes Following Cytoreductive Nephrectomy: A Multi-institutional Analysis of 1272 Consecutive PatientsAshanda R Esdaille, Jose A Karam, Viraj A Master, et al.
Urologic Oncology|February 10, 2024
Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registryCesare Saitta, Jonathan A Afari, Arman Walia, et al.
Urologic Oncology|September 3, 2025
Proposed tripartite classification of T1 renal cell carcinoma: Comparison with current binary systemMargaret F Meagher, Giacomo Musso, Viraj Master, et al.
Clinical Genitourinary Cancer|April 2, 2026
The Effect of Allogenic Blood Transfusion on Oncologic Outcomes in Locally Advanced Kidney CancerTaryn A Ellis, Cindy J Hernandez, Veerain Gupta, et al.
Pageof 15

Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
BJU International|August 11, 2020
Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC)Brittney H Cotta, Margaret F Meagher, Dattatraya Patil, et al.
Clinical Genitourinary Cancer|January 1, 2023
Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFRJulia H Yuan, Hajime Tanaka, Dattatraya Patil, et al.
Clinical Genitourinary Cancer|April 26, 2026
Utilization, Cost, and Subsequent Salvage Treatment of Ablative Therapies for Localized Prostate Cancer in the United StatesNikhil T Sebastian, Dattatraya Patil, Pretesh R Patel, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Impact of Elevated C-Reactive Protein on Survival Outcomes of Patients with Small Renal Masses: A Retrospective Multicenter AnalysisMargaret F Meagher, Natalie Birouty, Giacomo Musso, et al.
The Oncologist|January 6, 2026
An Increase in Splenic Volume After First-Line Immunotherapy is Associated with Worse PFS in Patients with Metastatic Renal Cell CarcinomaGregory Palmateer, Ahmet Yildirim, Taylor Goodstein, et al.
European Journal of Radiology|April 25, 2018
Prospective evaluation of fluciclovine (<sup>18</sup>F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patientsOladunni Akin-Akintayo, Funmilayo Tade, Pardeep Mittal, et al.
Urology|September 10, 2023
Contemporary Patients Have Better Perioperative Outcomes Following Cytoreductive Nephrectomy: A Multi-institutional Analysis of 1272 Consecutive PatientsAshanda R Esdaille, Jose A Karam, Viraj A Master, et al.
Urologic Oncology|February 10, 2024
Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registryCesare Saitta, Jonathan A Afari, Arman Walia, et al.
Urologic Oncology|September 3, 2025
Proposed tripartite classification of T1 renal cell carcinoma: Comparison with current binary systemMargaret F Meagher, Giacomo Musso, Viraj Master, et al.
Clinical Genitourinary Cancer|April 2, 2026
The Effect of Allogenic Blood Transfusion on Oncologic Outcomes in Locally Advanced Kidney CancerTaryn A Ellis, Cindy J Hernandez, Veerain Gupta, et al.
Pageof 15